Prioritizing Sickle Cell Disease

Pediatrics. 2022 Dec 1;150(6):e2022059491. doi: 10.1542/peds.2022-059491.
No abstract available

MeSH terms

  • Anemia, Sickle Cell* / therapy
  • Humans
  • Hydroxyurea

Substances

  • Hydroxyurea